Immunohistology of liver allografts in recipients managed with prophylactic OKT3.
作者信息
Rohrer R J, Jenkins R L, Khettry U, Pinson C W, Gallik-Karlson C, Monaco A P
机构信息
Department of Surgery, New England Medical Center, Boston, MA 02111.
出版信息
Transplant Proc. 1989 Feb;21(1 Pt 2):2249-50.
PMID:2652729
Abstract
摘要
相似文献
1
Immunohistology of liver allografts in recipients managed with prophylactic OKT3.接受预防性OKT3治疗的受体中肝脏同种异体移植物的免疫组织学
Transplant Proc. 1989 Feb;21(1 Pt 2):2249-50.
2
Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.接受预防性OKT3或传统三联疗法的肝移植受者的淋巴细胞参数。
Transplant Proc. 1989 Feb;21(1 Pt 2):2255-6.
3
Histologic response to OKT3 therapy for hepatic allograft rejection.肝移植排斥反应的OKT3治疗的组织学反应
Transplant Proc. 1987 Feb;19(1 Pt 3):2459-61.
4
Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.血清OKT3水平低与原位肝移植患者预防排斥反应失败相关。
Transplant Proc. 1990 Aug;22(4):1774-6.
5
Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
Transplant Proc. 1989 Feb;21(1 Pt 2):1755-7.
6
Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
Transplant Proc. 1989 Feb;21(1 Pt 2):1747.
7
8
Use of OKT3 in kidney, pancreas, and liver transplantation.OKT3在肾脏、胰腺和肝脏移植中的应用。
Transplant Proc. 1990 Aug;22(4):1748-9.
9
Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.硫唑嘌呤、环孢素和类固醇对移植物及排斥反应细胞学模式的影响。
Transplant Proc. 1987 Feb;19(1 Pt 2):1650-1.
10
Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.在四联免疫抑制方案中MALG治疗持续时间的影响。
Transplant Proc. 1989 Feb;21(1 Pt 2):1726-8.
引用本文的文献
1
Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.莫罗单抗-CD3：对其药理学及作为实体器官移植排斥反应预防药物应用的重新评估。
Drugs. 1996 May;51(5):865-94. doi: 10.2165/00003495-199651050-00010.
Zotero 插件